| An Engineered Fusion Protein Anti-CD19(Fab)-LDM Effectively Inhibits ADR-Resistant B Cell Lymphoma | |
| Fan Dongmei; Jiang Linlin; Song Yuewen; Bao Shiqi; Yang Yuanyuan; Yuan Xiangfei; Zhen Yongsu; Yang Ming; Xiong Dongsheng | |
| 2019 | |
| 卷号 | 9页码:861 |
| 关键词 | BJAB cell line BJAB/ADR cell line adriamycin anti-CD19(Fab)-LDM engineered fusion protein |
| ISSN号 | 2234-943X |
| DOI | 10.3389/fonc.2019.00861 |
| URL标识 | 查看原文 |
| 收录类别 | PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6335710 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Fan Dongmei,Jiang Linlin,Song Yuewen,et al. An Engineered Fusion Protein Anti-CD19(Fab)-LDM Effectively Inhibits ADR-Resistant B Cell Lymphoma[J],2019,9:861. |
| APA | Fan Dongmei.,Jiang Linlin.,Song Yuewen.,Bao Shiqi.,Yang Yuanyuan.,...&Xiong Dongsheng.(2019).An Engineered Fusion Protein Anti-CD19(Fab)-LDM Effectively Inhibits ADR-Resistant B Cell Lymphoma.,9,861. |
| MLA | Fan Dongmei,et al."An Engineered Fusion Protein Anti-CD19(Fab)-LDM Effectively Inhibits ADR-Resistant B Cell Lymphoma".9(2019):861. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论